"Clinical Laboratory, Molecular Diagnostic and Genomic Testing Services - 2016 to 2019 Global Version" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2015 Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions.
Forecast demand for new testing regimes or technologies. Make research investment decisions. Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand.
Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges.
The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.
Companies Mentioned Include:
ARUP Laboratories, Inc.
Ascend Clinical, LLC
Diagnósticos da América (DASA)
DL Reference Laboratory
Enzo Biochem, Inc.
Exagen Diagnostics, Inc.
Personal Genome Diagnostics
Predictive Biosciences, Inc.
Vira Cor-Ibt Laboratories
1. Introduction and Market Definition
2. Market Overview
3. Market Trends
4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments
5. Country Market Sizes - North America
6. Country Markets - Europe
7. Country Markets - Asia Pacific
8. Country Markets - Latin America, Africa & The Middle East